This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koskinen, P. K. Articles by Hayry, P. J. Search for Related Content PubMed PubMed Citation Articles by Koskinen, P. K. Articles by Hayry, P. J.

American Journal of Pathology, Vol 146, 972-980, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts

PK Koskinen, KB Lemstrom and PJ Hayry
Transplantation Laboratory, University of Helsinki, Finland.

Accelerated allograft arteriosclerosis (chronic rejection) has emerged as a major factor affecting long-term survival of human cardiac allografts. The underlying mechanism of this disorder remains unclear. The purpose of this study was to investigate the effect of cyclosporine on the development of cardiac allograft arteriosclerosis at the cellular and molecular level. Heterotopic rat cardiac allografts from DA donors to WF recipients, with a strong genetic disparity in major histocompatibility complex and non-major histocompatibility complex loci, were used. The allograft recipients received triple-drug immunosuppression consisting of methylprednisolone (0.5 mg/kg/day), azathioprine (2 mg/kg/day), and three different doses of cyclosporine A (CsA; 5, 10, and 20 mg/kg/day). The grafts were removed 3 months after transplantation and processed for histology and immunohistochemistry. Low dose CsA (5 mg/kg/day) was associated with a severe form of intimal cell accumulation and intimal thickening in epicardial arteries and in smaller intramyocardial arterioles with nearly occluded vessel lumens 3 months after transplantation. The intermediate dose CsA (10 mg/kg/day) significantly inhibited arterial intimal thickening but was not efficient in reducing intimal cell accumulation. Instead, high dose CsA (20 mg/kg/day) significantly inhibited all arteriosclerotic vascular wall changes in the allografts. Immunohistochemistry revealed that the occluded epicardial arteries of cardiac allografts with low dose CsA expressed VCAM-1 on the endothelium. Higher CsA doses significantly reduced the expression of endothelial VCAM-1. Neither ICAM-1 nor major histocompatibility complex class II were expressed. Perivascular arterial infiltrates consisting of T helper cells and monocytes/macrophages were a characteristic finding in the allograft with low dose CsA. In the allografts treated with higher doses of CsA, arterial perivascular infiltrates were seldom seen. Our results conclusively demonstrate that sufficient immunosuppression with CsA inhibits intimal thickening and intimal cell accumulation of long- surviving rat cardiac allografts in a dose-dependent fashion. Arteriosclerotic alterations associated with increased expression of arterial endothelial VCAM-1 were totally down-regulated by high doses of CsA.

This article has been cited by other articles:

				A. Izawa, T. Ueno, M. Jurewicz, T. Ito, K. Tanaka, M. Takahashi, U. Ikeda, O. Sobolev, P. Fiorina, R. N. Smith, et al. Importance of Donor- and Recipient-Derived Selectins in Cardiac Allograft Rejection J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2929 - 2936. [Abstract] [Full Text] [PDF]

				A. I. Nykanen, R. Krebs, A. Saaristo, P. Turunen, K. Alitalo, S. Yla-Herttuala, P. K. Koskinen, and K. B. Lemstrom Angiopoietin-1 Protects Against the Development of Cardiac Allograft Arteriosclerosis Circulation, March 11, 2003; 107(9): 1308 - 1314. [Abstract] [Full Text] [PDF]

				J. Dudley, C. Truman, M. McGraw, J. Tizard, G. Haque, and B. Bradley Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation Nephrol. Dial. Transplant., February 1, 2003; 18(2): 403 - 410. [Abstract] [Full Text] [PDF]

				R. K. Sihvola, V. P. Pulkkinen, P. K. Koskinen, and K. B. Lemstrom Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis J. Am. Coll. Cardiol., February 20, 2002; 39(4): 710 - 717. [Abstract] [Full Text] [PDF]

				R. S. Poston, M. Billingham, E. G. Hoyt, J. Pollard, R. Shorthouse, R. E. Morris, and R. C. Robbins Rapamycin Reverses Chronic Graft Vascular Disease in a Novel Cardiac Allograft Model Circulation, July 6, 1999; 100(1): 67 - 74. [Abstract] [Full Text] [PDF]

				H. O. Andersen, B. F. Hansen, P. Holm, S. Stender, and B. G. Nordestgaard Effect of Cyclosporine on Arterial Balloon Injury Lesions in Cholesterol-Clamped Rabbits : T Lymphocyte–Mediated Immune Responses Not Involved in Balloon Injury–Induced Neointimal Proliferation Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1687 - 1694. [Abstract] [Full Text] [PDF]

				R. Sihvola, P. Koskinen, M. Myllarniemi, M. Loubtchenkov, P. Hayry, E. Buchdunger, and K. Lemstrom Prevention of Cardiac Allograft Arteriosclerosis by Protein Tyrosine Kinase Inhibitor Selective for Platelet-Derived Growth Factor Receptor Circulation, May 4, 1999; 99(17): 2295 - 2301. [Abstract] [Full Text] [PDF]

				H. Holschermann, O. Kohl, U. Maus, F. Durfeld, A. Bierhaus, P. P. Nawroth, J. Lohmeyer, H. Tillmanns, and W. Haberbosch Cyclosporin A Inhibits Monocyte Tissue Factor Activation in Cardiac Transplant Recipients Circulation, December 16, 1997; 96(12): 4232 - 4238. [Abstract] [Full Text]

				H. O. Andersen, P. Holm, S. Stender, B. F. Hansen, and B. G. Nordestgaard Dose-Dependent Suppression of Transplant Arteriosclerosis in Aorta-Allografted, Cholesterol-Clamped Rabbits : Suppression Not Eliminated by the Cholesterol-Raising Effect of Cyclosporine Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2515 - 2523. [Abstract] [Full Text]

				K. B. Lemstrom and P. K. Koskinen Expression and Localization of Platelet-Derived Growth Factor Ligand and Receptor Protein During Acute and Chronic Rejection of Rat Cardiac Allografts Circulation, August 19, 1997; 96(4): 1240 - 1249. [Abstract] [Full Text]

				P. K. Koskinen and K. B. Lemstrom Adhesion Molecule P-Selectin and Vascular Cell Adhesion Molecule–1 in Enhanced Heart Allograft Arteriosclerosis in the Rat Circulation, January 7, 1997; 95(1): 191 - 196. [Abstract] [Full Text]

				K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]